Samsara BioCapital as of Dec. 31, 2021
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 49 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Graphite Bio | 18.9 | $98M | 7.9M | 12.43 | |
Chinook Therapeutics | 14.5 | $75M | 4.6M | 16.31 | |
Instil Bio | 6.6 | $34M | 2.0M | 17.11 | |
Nkarta (NKTX) | 6.1 | $31M | 2.0M | 15.35 | |
Sutro Biopharma (STRO) | 4.8 | $25M | 1.7M | 14.88 | |
Forma Therapeutics Hldgs SHS | 4.3 | $22M | 1.6M | 14.22 | |
Iveric Bio | 4.1 | $21M | 1.3M | 16.72 | |
Rain Therapeutics | 3.9 | $20M | 1.6M | 12.88 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.2 | $16M | 1.5M | 11.26 | |
Novavax Com New (NVAX) | 3.0 | $16M | 110k | 143.05 | |
Aclaris Therapeutics (ACRS) | 2.2 | $12M | 794k | 14.54 | |
Science 37 Holdings | 2.2 | $11M | 900k | 12.47 | |
Intercept Pharmaceuticals In | 2.0 | $10M | 641k | 16.29 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 1.8 | $9.2M | 539k | 17.13 | |
Springworks Therapeutics (SWTX) | 1.7 | $8.7M | 140k | 61.98 | |
Janux Therapeutics (JANX) | 1.6 | $8.1M | 412k | 19.73 | |
Verona Pharma Sponsored Ads (VRNA) | 1.4 | $7.5M | 1.1M | 6.72 | |
Io Biotech (IOBT) | 1.4 | $7.2M | 1.1M | 6.40 | |
Tango Therapeutics (TNGX) | 1.3 | $6.9M | 630k | 10.94 | |
Syros Pharmaceuticals | 1.2 | $6.2M | 2.2M | 2.85 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 1.1 | $5.9M | 480k | 12.24 | |
Elevation Oncology (ELEV) | 1.1 | $5.6M | 932k | 6.02 | |
Avadel Pharmaceuticals Sponsored Adr | 1.0 | $5.3M | 659k | 8.08 | |
Jiya Acquisition Corp Com Cl A | 1.0 | $5.0M | 507k | 9.77 | |
Aeglea Biotherapeutics | 0.8 | $4.2M | 884k | 4.75 | |
Decibel Therapeutics | 0.7 | $3.8M | 826k | 4.65 | |
Bolt Biotherapeutics (BOLT) | 0.7 | $3.6M | 738k | 4.90 | |
Rhythm Pharmaceuticals (RYTM) | 0.7 | $3.4M | 345k | 9.98 | |
Day One Biopharmaceuticals I (DAWN) | 0.7 | $3.4M | 203k | 16.85 | |
Allakos (ALLK) | 0.6 | $3.3M | 340k | 9.79 | |
Bcls Acquisition Corp Com Cl A | 0.6 | $2.9M | 300k | 9.80 | |
Viracta Therapeutics (VIRX) | 0.5 | $2.6M | 711k | 3.65 | |
Albireo Pharma | 0.5 | $2.3M | 100k | 23.29 | |
Equillium (EQ) | 0.5 | $2.3M | 616k | 3.77 | |
Immunocore Hldgs Ads (IMCR) | 0.4 | $2.2M | 64k | 34.23 | |
Terns Pharmaceuticals (TERN) | 0.4 | $2.0M | 289k | 7.07 | |
Surrozen | 0.4 | $1.9M | 300k | 6.44 | |
Vtv Therapeutics Cl A | 0.3 | $1.6M | 1.6M | 0.99 | |
Atreca Cl A Com (BCEL) | 0.2 | $1.2M | 397k | 3.03 | |
Allovir (ALVR) | 0.2 | $1.1M | 82k | 12.93 | |
Kronos Bio (KRON) | 0.2 | $1.1M | 78k | 13.59 | |
Biontech Se Sponsored Ads (BNTX) | 0.2 | $1.0M | 4.0k | 257.75 | |
Vistagen Therapeutics | 0.2 | $953k | 489k | 1.95 | |
Odonate Therapeutics Ord | 0.2 | $946k | 700k | 1.35 | |
Rocket Pharmaceuticals (RCKT) | 0.2 | $885k | 41k | 21.82 | |
Kala Pharmaceuticals | 0.1 | $727k | 601k | 1.21 | |
Ngm Biopharmaceuticals | 0.0 | $242k | 14k | 17.70 | |
Astria Therapeutics (ATXS) | 0.0 | $135k | 25k | 5.40 | |
Amarin Corp Spons Adr New (AMRN) | 0.0 | $84k | 25k | 3.36 |